ResearcherHarvard UniversityNo recent work listed

David Avigan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4624-6017; OpenAlex author ID A5052641327. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Personalized tumor vaccine for pancreatic cancer. Last author DOI 10.1007/s00262-022-03237-x ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shira Orr · 1 shared paper, 2023 · strength 0.15
- Paper Personalized tumor vaccine for pancreatic cancer. DOI 10.1007/s00262-022-03237-x ↗
Ling Huang · 1 shared paper, 2023 · strength 0.15
- Paper Personalized tumor vaccine for pancreatic cancer. DOI 10.1007/s00262-022-03237-x ↗
Manuel M. Hidalgo · 1 shared paper, 2023 · strength 0.15
- Paper Personalized tumor vaccine for pancreatic cancer. DOI 10.1007/s00262-022-03237-x ↗
Donald W. Kufe · 1 shared paper, 2023 · strength 0.15
- Paper Personalized tumor vaccine for pancreatic cancer. DOI 10.1007/s00262-022-03237-x ↗
Senthil K. Muthuswamy · 1 shared paper, 2023 · strength 0.15
- Paper Personalized tumor vaccine for pancreatic cancer. DOI 10.1007/s00262-022-03237-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.